XML Financial LLC Invests $554,000 in Amrize Ltd $AMRZ

XML Financial LLC bought a new position in shares of Amrize Ltd (NYSE:AMRZFree Report) during the first quarter, Holdings Channel.com reports. The fund bought 9,889 shares of the company’s stock, valued at approximately $554,000.

Other large investors have also recently bought and sold shares of the company. Norges Bank bought a new stake in Amrize in the 4th quarter valued at $929,333,000. Harris Associates L P acquired a new stake in Amrize in the 4th quarter worth $615,406,000. Wellington Management Group LLP increased its holdings in shares of Amrize by 48.8% during the 3rd quarter. Wellington Management Group LLP now owns 11,622,024 shares of the company’s stock worth $561,018,000 after purchasing an additional 3,809,133 shares during the period. Marshall Wace LLP increased its holdings in shares of Amrize by 865.4% during the 3rd quarter. Marshall Wace LLP now owns 2,889,660 shares of the company’s stock worth $139,436,000 after purchasing an additional 2,590,336 shares during the period. Finally, Barclays PLC increased its holdings in shares of Amrize by 95.4% during the 4th quarter. Barclays PLC now owns 4,614,593 shares of the company’s stock worth $249,557,000 after purchasing an additional 2,253,431 shares during the period.

Insider Buying and Selling at Amrize

In other Amrize news, CEO Jan Philipp Jenisch bought 3,000 shares of the stock in a transaction that occurred on Tuesday, May 19th. The shares were acquired at an average price of $49.96 per share, with a total value of $149,880.00. Following the completion of the purchase, the chief executive officer directly owned 515,000 shares in the company, valued at $25,729,400. The trade was a 0.59% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, insider Mario Gross purchased 1,200 shares of the company’s stock in a transaction that occurred on Wednesday, May 20th. The stock was acquired at an average cost of $48.63 per share, with a total value of $58,356.00. Following the transaction, the insider directly owned 34,747 shares of the company’s stock, valued at approximately $1,689,746.61. This represents a 3.58% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. In the last three months, insiders acquired 54,920 shares of company stock worth $2,717,429. Insiders own 0.54% of the company’s stock.

Amrize Stock Down 3.4%

AMRZ opened at $53.49 on Tuesday. Amrize Ltd has a fifty-two week low of $44.12 and a fifty-two week high of $65.94. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.40 and a quick ratio of 0.89. The firm’s fifty day moving average price is $54.01 and its two-hundred day moving average price is $55.66. The company has a market capitalization of $29.58 billion and a P/E ratio of 25.59.

Amrize (NYSE:AMRZGet Free Report) last announced its quarterly earnings results on Wednesday, April 29th. The company reported ($0.16) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.14) by ($0.02). Amrize had a net margin of 9.70% and a return on equity of 9.84%. The business had revenue of $2.18 billion during the quarter. The business’s revenue for the quarter was up 4.7% on a year-over-year basis. On average, analysts anticipate that Amrize Ltd will post 2.76 EPS for the current year.

Amrize Cuts Dividend

The firm also recently announced a dividend, which was paid on Wednesday, May 20th. Stockholders of record on Tuesday, May 12th were given a dividend of $0.11 per share. The ex-dividend date was Tuesday, May 12th. Amrize’s payout ratio is 21.05%.

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on the stock. Stephens reiterated an “overweight” rating and issued a $65.00 target price on shares of Amrize in a research note on Monday, May 18th. Wall Street Zen raised Amrize from a “sell” rating to a “hold” rating in a research report on Sunday, March 1st. Wells Fargo & Company lowered their price target on Amrize from $66.00 to $65.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 15th. Oppenheimer set a $68.00 price target on Amrize in a report on Friday, May 1st. Finally, Citigroup reduced their price objective on Amrize from $76.00 to $66.00 and set a “buy” rating for the company in a research report on Monday, May 4th. One research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and six have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $64.71.

View Our Latest Stock Report on Amrize

Amrize Profile

(Free Report)

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.

Featured Stories

Want to see what other hedge funds are holding AMRZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amrize Ltd (NYSE:AMRZFree Report).

Institutional Ownership by Quarter for Amrize (NYSE:AMRZ)

Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.